| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 1570.38% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
| 08/11/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 07/13/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 06/06/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 05/22/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/31/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 12/13/2022 | 1848.78% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 12/01/2022 | 1570.38% | JonesTrading | → $6 | Initiates Coverage On | → Buy |
| 04/01/2022 | 1570.38% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
| 06/30/2021 | 2962.36% | Roth Capital | $9 → $11 | Maintains | Buy |
| 12/18/2020 | 1291.98% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 04/28/2020 | 1987.97% | Brookline Capital | → $7.5 | Initiates Coverage On | → Buy |
What is the target price for Dare Bioscience (DARE)?
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on November 10, 2023. The analyst firm set a price target for $6.00 expecting DARE to rise to within 12 months (a possible 1570.38% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Dare Bioscience (DARE)?
The latest analyst rating for Dare Bioscience (NASDAQ: DARE) was provided by HC Wainwright & Co., and Dare Bioscience maintained their buy rating.
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating Dare Bioscience (DARE) correct?
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a maintained with a price target of $7.00 to $6.00. The current price Dare Bioscience (DARE) is trading at is $0.36, which is out of the analyst's predicted range.